Guidelines for using five new prenatal laboratory tests.
All physicians, even those not routinely involved in prenatal care, should be aware of the laboratory tests recently recommended for inclusion in prenatal care. All pregnant women should undergo blood glucose testing to detect gestational diabetes mellitus. Women at risk for hepatitis B, Chlamydia trachomatis infection, or human immunodeficiency virus infections should be tested. All women should also be offered alpha fetoprotein testing for detection of neural tube defects. If test results are abnormal, appropriate management and/or counseling should be provided.
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002690:Chlamydia Infections / Q000175:diagnosis; D002692:Chlamydia trachomatis; D005260:Female; D006678:HIV / Q000276:immunology; D015483:HIV Antibodies; D006509:Hepatitis B / Q000175:diagnosis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D009436:Neural Tube Defects / Q000175:diagnosis*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D011254:Pregnancy in Diabetics / Q000175:diagnosis*; D011296:Prenatal Diagnosis; D000509:alpha-Fetoproteins / Q000032:analysis
D000914:Antibodies, Viral; D015483:HIV Antibodies; D006514:Hepatitis B Surface Antigens; D000509:alpha-Fetoproteins